General Information of Drug Off-Target (DOT) (ID: OTVQQSMK)

DOT Name Neuronal acetylcholine receptor subunit alpha-2 (CHRNA2)
Gene Name CHRNA2
Related Disease
Autosomal dominant nocturnal frontal lobe epilepsy 4 ( )
Autosomal dominant nocturnal frontal lobe epilepsy ( )
Benign familial infantile epilepsy ( )
Sleep-related hypermotor epilepsy ( )
UniProt ID
ACHA2_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
5FJV
Pfam ID
PF02931 ; PF02932
Sequence
MGPSCPVFLSFTKLSLWWLLLTPAGGEEAKRPPPRAPGDPLSSPSPTALPQGGSHTETED
RLFKHLFRGYNRWARPVPNTSDVVIVRFGLSIAQLIDVDEKNQMMTTNVWLKQEWSDYKL
RWNPTDFGNITSLRVPSEMIWIPDIVLYNNADGEFAVTHMTKAHLFSTGTVHWVPPAIYK
SSCSIDVTFFPFDQQNCKMKFGSWTYDKAKIDLEQMEQTVDLKDYWESGEWAIVNATGTY
NSKKYDCCAEIYPDVTYAFVIRRLPLFYTINLIIPCLLISCLTVLVFYLPSDCGEKITLC
ISVLLSLTVFLLLITEIIPSTSLVIPLIGEYLLFTMIFVTLSIVITVFVLNVHHRSPSTH
TMPHWVRGALLGCVPRWLLMNRPPPPVELCHPLRLKLSPSYHWLESNVDAEEREVVVEEE
DRWACAGHVAPSVGTLCSHGHLHSGASGPKAEALLQEGELLLSPHMQKALEGVHYIADHL
RSEDADSSVKEDWKYVAMVIDRIFLWLFIIVCFLGTIGLFLPPFLAGMI
Function After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane.
KEGG Pathway
Neuroactive ligand-receptor interaction (hsa04080 )
Reactome Pathway
Highly calcium permeable nicotinic acetylcholine receptors (R-HSA-629597 )
Highly calcium permeable postsynaptic nicotinic acetylcholine receptors (R-HSA-629594 )

Molecular Interaction Atlas (MIA) of This DOT

4 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Autosomal dominant nocturnal frontal lobe epilepsy 4 DIS8N0WD Strong Autosomal dominant [1]
Autosomal dominant nocturnal frontal lobe epilepsy DISE3C4O Supportive Autosomal dominant [1]
Benign familial infantile epilepsy DISFYXOW Disputed Autosomal dominant [2]
Sleep-related hypermotor epilepsy DISWP477 Limited Autosomal dominant [2]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
This DOT Affected the Drug Response of 3 Drug(s)
Drug Name Drug ID Highest Status Interaction REF
Carbamazepine DMZOLBI Approved Neuronal acetylcholine receptor subunit alpha-2 (CHRNA2) affects the response to substance of Carbamazepine. [6]
Nicotine DMWX5CO Approved Neuronal acetylcholine receptor subunit alpha-2 (CHRNA2) affects the response to substance of Nicotine. [6]
Acetylcholine DMDF79Z Approved Neuronal acetylcholine receptor subunit alpha-2 (CHRNA2) affects the response to substance of Acetylcholine. [6]
------------------------------------------------------------------------------------
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Neuronal acetylcholine receptor subunit alpha-2 (CHRNA2). [3]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Neuronal acetylcholine receptor subunit alpha-2 (CHRNA2). [5]
------------------------------------------------------------------------------------
2 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Calcitriol DM8ZVJ7 Approved Calcitriol increases the expression of Neuronal acetylcholine receptor subunit alpha-2 (CHRNA2). [4]
Testosterone DM7HUNW Approved Testosterone increases the expression of Neuronal acetylcholine receptor subunit alpha-2 (CHRNA2). [4]
------------------------------------------------------------------------------------

References

1 Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear. Am J Hum Genet. 2006 Aug;79(2):342-50. doi: 10.1086/506459. Epub 2006 Jun 26.
2 Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6.
3 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
4 Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer. 2011 May 18;10:58.
5 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
6 Pleiotropic functional effects of the first epilepsy-associated mutation in the human CHRNA2 gene. FEBS Lett. 2009 May 19;583(10):1599-604. doi: 10.1016/j.febslet.2009.04.024. Epub 2009 Apr 19.